Expression of CD99 in pleomorphic carcinomas of the lung

Journal of Korean Medical Science

Volumn 20, Issue 1, 2005, Pages 50-55

  Yoo, Seong Ho ^a   Han, Jungho ^b   Tae, Jin Kim ^b   Doo, Hyun Chung ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

CD99 Protein; Human; Lung Neoplasms; Pleomorphic Carcinoma

Indexed keywords

CD99 ANTIGEN; CYTOKERATIN 20; CYTOKERATIN 7; THYROID TRANSCRIPTION FACTOR 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LUNG CARCINOMA; MALE; PATHOLOGY; PROTEIN EXPRESSION; SPINDLE CELL; SURVIVAL RATE;

EID: 14844326295     PISSN: 10118934     EISSN: None     Source Type: Journal    
DOI: 10.3346/jkms.2005.20.1.50     Document Type: Article

References (37)

1. Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001; 18: 1059-68.
2. Travis WD. Pathology of lung cancer. Clin Chest Med 2002; 23: 65-81.
3. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995; 75: 191-202.
4. Travis WD, Colby TV, Corrin B. Histopathological Typing of Lung and Pleural Tumours. New York: Springer Verlag, 1999.
5. Addis BJ, Corrin B. Pulmonary blastoma, carcinosarcoma and spindle-cell carcinoma: an immunohistochemical study of keratin intermediate filaments. J Pathol 1985; 147: 291-301.
6. Battifora H. Spindle cell carcinoma: ultrastructural evidence of squamous origin and collagen production by the tumor cells. Cancer 1976; 37: 2275-82.
7. Berho M, Moran CA, Suster S. Malignant mixed epithelial/mesenchymal neoplasms of the lung. Semin Diagn Pathol 1995; 12: 123-39.
8. Cagle PT, Alpert LC, Carmona PA. Peripheral biphasic adenocarcinoma of the lung: light microscopic and immunohistochemical findings. Hum Pathol 1992; 23: 197-200.
9. Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lung Cancer 2001; 34: 91-7.
10. Attanoos RL, Papagiannis A, Suttinont P, Goddard H, Papotti M, Gibbs AR. Pulmonary giant cell carcinoma: pathological entity or morphological phenotype? Histopathology 1998; 32: 225-31.
11. Fishback NF, Travis WD, Moran CA, Guinee DG Jr, McCarthy WF, Koss MN. Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases. Cancer 1994; 73: 2936-45.
12. Nakajima M, Kasai T, Hashimoto H, Iwata Y, Manabe H. Sarcomatoid carcinoma of the lung: a clinicopathologic study of 37 cases. Cancer 1999; 86: 608-16.
13. Nappi O, Glasner SD, Swanson PE, Wick MR. Biphasic and monophasic sarcomatoid carcinomas of the lung. A reappraisal of 'carcinosarcomas' and 'spindle-cell carcinomas'. Am J Clin Pathol 1994; 102: 331-40.
14. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik M. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer 1991; 67: 1886-93.
15. Kovar H. Dworzak M, Strehl S, Schnell E, Ambros IM, Ambros PF, Gadner H. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Oncogens 1990; 5: 1067-70.
16. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G. The Ewing family of tumors--a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994; 331: 294-9.
17. Ozdemirli M, Fanburg-Smith JC, Hartmann DP, Azumi N, Miettinen M. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement. Mod Pathol 2001; 14: 1175-82.
18. Costa MJ, Ames PF, Walls J, Roth LM. Inhibin immunohistochemistry applied to ovarian neoplasms: a novel, effective, diagnostic tool. Hum Pathol 1997; 28: 1247-54.
19. Pelosi G, Fraggetta F, Sonzogni A, Fazio N, Cavallon A, Viale G. CD99 immunoreactivity in gastrointestinal and pulmonary neuroendocrine tumours. Virchows Arch 2000; 437: 270-4.
20. Jung KC, Kim NH, Park WS, Park SH, Bae Y. The CD99 signal enhances Fas-mediated apoptosis in the human leukemic cell line, Jurkat. FEBS Lett 2003 20; 554: 478-84.
21. Fisher C. Synovial sarcoma. Ann Diagn Pathol 1998; 2: 401-21.
22. Gordon MD, Corless C, Renshaw AA, Beckstead J. CD99, keratin, and vimentin staining of sex cord-stromal tumors, normal ovary, and testis. Mod Pathol 1998; 11: 769-73.
23. Shin YK, Lee GK, Kook MC, Jung KC, Kim JR, Song HG, Park SH, Chi JG. Reduced expression of CD99 and functional disturbance in anencephalic cortical thymocytes. Virchows Arch 1999; 434: 443-9.
24. Matias-Guiu X, Pons C, Prat J. Mullerian inhibiting substance, alpha-inhibin, and CD99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors. Hum Pathol 1998; 29: 840-5.
25. Weidner N, Tjoe J. Immunohistochemical profile of monoclonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma. Am J Surg Pathol 1994; 18: 486-94.
26. Granter SR, Renshaw AA, Fletcher CD, Bhan AK, Rosenberg AE. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol 1996; 27: 1273-6.
27. Jung KC, Park WS, Bae YM, Hahn JH, Hahn K, Lee H, Lee HW, Koo HJ, Shin HJ, Shin HS, Park YE, Park SH. Immunoreactivity of CD99 in stomach cancer. J Korean Med Sci 2002; 17: 483-9.
28. Lee EJ, Lee HG, Park SH, Choi EY, Park SH. CD99 type II is a determining factor for the differentiation of primitive neuroectodermal cells. Exp Mol Med 2003; 35: 538-47.
29. Lee IS, Kim SH, Song HG, Park SH. The molecular basis for the generation of Hodgkin and Reed-Sternberg cells in Hodgkin's lymphoma. Int J Hematol 2003; 77: 330-5.
30. Lee HJ, Kim E, Jee B, Hahn JH, Han K, Jung KC, Park SH, Lee H. Functional involvement of src and focal adhesion kinase in a CD99 splice variant-induced motility of human breast cancer cells. Exp Mol Med 2002; 34: 177-83.
31. Lee IS, Shin YK, Chung DH, Park SH. LMP-I induced downregulation of CD99 molecules in Hodgkin's and Reed-Sternberg cells. Leuk Lymphoma 2001; 42: 587-94.
32. Sohn HW, Choi EY, Kim SH, Lee IS, Chung DH, Sung UA, Hwang DH, Cho SS, Jun BH, Jang JJ, Chi JG, Park SH. Engagement of CD99 induces apoptosis through calcineurin-independent pathway in Ewing's sarcoma cells. Am J Pathol 1998; 153: 1937-45.
33. Kim SH, Choi EY, Shin YK, Kim TJ, Chung DH, Chang SI, Kim NK, Park SH. Generation of cells with Hodgkin's and Reed-Sternberg phenotype through downregulation of CD99 (MIC2). Blood 1998; 92: 4287-95.
34. Rossi G, Cavazza A, Sturm N, Migaldi M, Facciolongo N, Longo L, Maiorana A, Brambilla E. Pulmonary carcinomas with pleomorphic, sarcomatoid, or sarcomatous elements: a clinicopathologic and immunohistochemical study of 75 cases. Am J Surg Pathol 2003; 27: 311-24.
35. Dacic S, Finkelstein SD, Sasotomi E, Swalsky PA, Yousem SA. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdisection-based allelotyping. Am J Surg Pathol 2002; 26: 510-6.
36. Holst VA, Finkelstein S, Colby TV, Myers JL, Yousem SA. p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implication for histogenesis. Am J Surg Pathol 1997; 21: 801-11.
37. Thompson L, Chang B, Barsky SH. Mononclonal origins of malignant mixed tumors (carcinosarcomas): evidence for a divergent histogenesis. Am J Surg Pathol 1996; 20: 277-85.